Verfügbarkeit: New generation vaccines

New generation vaccines:

Gespeichert in:

Bibliographische Detailangaben
Format:	Buch
Sprache:	English
Veröffentlicht:	New York [u.a.] Dekker 1997
Ausgabe:	2. ed., rev. and expanded
Schlagworte:	Antigenen Infectieziekten Vaccins Vacinas Vaccines Impfstoff
Online-Zugang:	Inhaltsverzeichnis
Beschreibung:	XVI, 1214 S. Ill., graph. Darst.
ISBN:	0824700619

Internformat

MARC


LEADER	00000nam a2200000 c 4500
001	BV012270608
003	DE-604
005	19981120
007	t
008	981118s1997 ad\|\| \|\|\|\| 00\|\|\| eng d
020			\|a 0824700619 \|9 0-8247-0061-9
035			\|a (OCoLC)36682381
035			\|a (DE-599)BVBBV012270608
040			\|a DE-604 \|b ger \|e rakddb
041	0		\|a eng
049			\|a DE-20
050		0	\|a QR189
082	0		\|a 615/.372 \|2 21
084			\|a XD 3300 \|0 (DE-625)152554:12905 \|2 rvk
245	1	0	\|a New generation vaccines \|c ed. by Myron M. Levine ...
250			\|a 2. ed., rev. and expanded
264		1	\|a New York [u.a.] \|b Dekker \|c 1997
300			\|a XVI, 1214 S. \|b Ill., graph. Darst.
336			\|b txt \|2 rdacontent
337			\|b n \|2 rdamedia
338			\|b nc \|2 rdacarrier
650		7	\|a Antigenen \|2 gtt
650		7	\|a Infectieziekten \|2 gtt
650		7	\|a Vaccins \|2 gtt
650		7	\|a Vacinas \|2 larpcal
650		4	\|a Vaccines
650	0	7	\|a Impfstoff \|0 (DE-588)4026655-2 \|2 gnd \|9 rswk-swf
689	0	0	\|a Impfstoff \|0 (DE-588)4026655-2 \|D s
689	0		\|5 DE-604
700	1		\|a Levine, Myron Max \|e Sonstige \|4 oth
856	4	2	\|m HBZ Datenaustausch \|q application/pdf \|u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008316561&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA \|3 Inhaltsverzeichnis
999			\|a oai:aleph.bib-bvb.de:BVB01-008316561

Datensatz im Suchindex

_version_	1804126890856808448
adam_text	Contents Preface Hi Contributors x Part I: Introduction to Vaccinology 1. Vaccines and Vaccination in Historical Perspective 1 Myron M. Levine and Rosanna Lagos 2. The Traditional Vaccines: An Overview 13 Gordon L. Ada 3. An Overview of Biotechnology as Applied to Vaccine Development 25 Graeme C. Woodrow 4. Initial Clinical Evaluation of New Vaccine Candidates: Phase 1 and 2 Clinical Trials of Safety, Immunogenicity, and Preliminary Efficacy 35 Carol 0. Jacket, Martha J. Mattheis, and Margaret Baker Rennels 5. Long Term Evaluation of Vaccine Protection: Methodological Issues for Phase 3 Trials and Phase 4 Studies 47 John D. Clemens, Abdollah Naficy, and Malta R. Rao 6. Economic Analyses of Vaccines and Vaccination Programs: Evaluating the Economic Rationale for Immunization 69 Orin S. Levine and Benjamin Schwartz 7. Reaping the Benefits: Getting Vaccines to Those Who Need Them 79 J. W. Lee, Bruce Aylward, Harry F. Hull, Amie Batson, Maureen E. Birmingham, and John Lloyd 8. Progress and Challenges in Modern Vaccinology: An Immunologist s Perspective 89 Gustav J. V. Nossal 9. The Eradication of Vaccine Preventable Diseases 93 William Foege Part II: Molecular Immunology as Applied to Vaccine Development 10. Recent Advances in Immunology: Impact on Vaccine Development 99 Marcelo B. Sztein and Graham F. Mitchell 11. Computer Prediction of T Cell Epitopes 127 Anne S. De Groot, Gabriel E. Meister, James L. Cornette, Hanah Margalit, Charles DeLisi, and Jay A. Berzofsky 12. Identification of B and T Cell Epitopes Through Structural Characterization and Peptide Technology .. 139 Juan A. Cooper and Allan J. Saul v vi • Contents 13. The Gastrointestinal Mucosal Immune System 151 Stephen P. James Part III: Immunopotentiation, Adjuvants, Nonliving Antigen Delivery Systems, and Naked DNA Vaccines 14. Adjuvants for the Future 173 Robert Edelman 15. Proteosomes for Improved Nasal, Oral, or Injectable Vaccines 193 George H. Lowell 16. Liposomes as Adiuvants for Vaccines 207 Carl R. Alving 17. Prospects for the Development of New and Improved Vaccines Through the Use of Microencapsulation Technology 215 Derek T. O Hagan 18. Antigen Cochleate Preparations for Oral and Systemic Vaccination 229 Raphael J. Mannino and Susan Gould Fogerite 19. Ty Virus like Particles as an Antigen Delivery System 239 Guy T. Layton 20. Immunopotentiating Reconstituted Influenza Virosomal Vaccine Delivery System 247 Reinhard Gliick and Stanley J. Cryz, Jr. 21. Mutant Pertussis and Escherichia coli Heat Labile Toxins as Adjuvants for Enhancing Local and Systemic Immune Responses to Coadministered, Nonliving Antigens 253 Gillian Douce, Gordon Dougan, MariaGrazia Pizza, Rino Rappuoli, and Mark Roberts 22. Oral Vaccine Production in the Edible Tissues of Transgenic Plants 263 Charles J. Arntzen and Hugh S. Mason 23. DNA Based Vaccines: Extending the Technology 279 Stephen Albert Johnston, Kathryn F. Sykes, and Michael A. Barry 24. Vaccination Against Influenza with Plasmid DNA: Cross Strain and Homologous Protection 287 John J. Donnelly, Jeffrey B. Ulmer, and Margaret A. Liu Part IV: Live Antigen Delivery Systems 25. Vaccinia Virus as a Live Vector for Expression of Immunogens 297 Charles Flexner and Bernard Moss 26. Attenuated Poliovirus as Live Vector 315 Matthias Gromeier, Hui Hua Lu, Steffen Mueller, Eckard Wimmer, and Louis Alexander 27. Attenuated Salmonella as a Live Vector for Expression of Foreign Antigens 331 i. Expressing Bacterial Antigens 331 5. N. Chatfield and Gordon Dougan ii. Carrying Viral Antigens 343 Florian Schodel iii. Salmonella Expressing Protozoal Antigens 351 Myron M. Levine, James E. Galen, Marcelo B. Sztein, Magda Beier, and Fernando Noriega Contents • vij 28. BCG as a Recombinant Vaccine Vector 363 Glenn J. Fennelly, William R. Jacobs, Jr., and Barry R. Bloom 29. Attenuated Vibrio cholerae as a Live Vector for Expression of Foreign Antigens 379 Joan R. Butterton and Stephen B. Calderwood Part V: New and Improved Vaccines Against Diseases for Which There Already Exist Licensed Vaccines 30. New and Improved Vaccines Against Pertussis 387 Erik L. Hewlett and James D. Cherry 31. New and Improved Vaccines Against Diphtheria and Tetanus 417 Rino Rappuoli 32. Progress in Development of New Attenuated Strains of Salmonella typhi as Live Oral Vaccines Against Typhoid Fever 437 Myron M. Levine, Carol O. Tacket, James E. Galen, Eileen M. Barry, S. N. Chatfield, Gordon Dougan, Fernando Noriega, and Marcelo B. Sztein 33. New and Improved Vaccines Against Cholera 447 i. Attenuated Vibrio cholerae 01 and 0139 Strains as Live Oral Cholera Vaccines 447 James B. Kaper, Carol 0. Tacket, and Myron M. Levine ii. Oral B Subunit Killed Whole Cell Cholera Vaccine 459 Jan Holmgren, Marianne Jertborn, and Ann Mari L. Svennerholm 34. New and Improved Vaccines Against Meningococcal Disease 469 Wendell D. Zollinger 35. Epidemiological Impact of Conjugate Vaccines on Invasive Disease Caused by Haemophilus influenzae Type b 489 Jay D. Wenger, Robert Booy, Paul T. Heath, and Richard Moxon 36. Conjugate Vaccines Against Streptococcus pneumoniae 503 David L. Klein and Ronald W. Ellis 37. Vaccine Development for Rickettsial Infections: Rocky Mountain Spotted Fever, Epidemic Typhus, and Scrub Typhus 527 Kimberly W. Schuenke and David H. Walker 38. New and Improved Vaccines Against Influenza 545 Mary Lou Clements and Ina Stephens 39. New Vaccines Against Hepatitis A 571 Jack T. Stapleton and Stanley M. Lemon 40. New and Improved Vaccines for Dengue, Japanese Encephalitis, and Yellow Fever Viruses 587 Niranjan Kanesa thasan, Robert Putnak, and Charles H. Hake, Jr. 41. Improved Vaccines Against Rabies 607 Then Fang Fu, Bernhard Dietzschold, Stanley A. Plotkin, and Charles E. Rupprecht 42. Combination Vaccines for Routine Infant Immunization: Prospects, Progress, and Dilemmas 619 Carole Heilman and N. Regina Rabinovich 43. New Vaccines Against Tuberculosis 631 Douglas Young and Uli Fruth viii • Contents 44. Live Attenuated Varicella Vaccines 647 Michiaki Takahashi and Anne A. Gershon Part VI: Vaccines Against Diseases for Which Licensed Vaccines Have Not Previously Been Available (or Which Have Not Been Widely Licensed) 45. Vaccines Against Rotavirus 659 Paul A. Offit, H. Fred Clark, and Albert Z. Kapikian 46. Experimental HIV 1 Vaccines 673 Mary Lou Clements 47. Vaccines Against Respiratory Syncytial Virus and Parainfluenza Virus Type 3 711 James E. Crowe, Jr., Peter L. Collins, Robert M. Chanock, and Brian R. Murphy 48. Herpes Simplex Vaccines 727 Richard J. Whitley 49. Vaccines Against Arenaviruses and Filoviruses 749 J. Christopher S. Clegg and Anthony Sanchez 50. Vaccines Against Papillomavirus Infections 767 Robert W. Tindle and Ian H. Frazer 51. Vaccines Against Streptococcus pyogenes Infections 783 Debra E. Bessen and Vincent A. Fischetti 52. O Specific Polysaccharide Protein Conjugates for Prevention of Enteric Bacterial Diseases 803 John B. Robbins, Rachel Schneerson, and Shousun C. Szu 53. Vaccines Against Gonococcal Infection 817 Timothy A. Mietzner and Myron S. Cohen 54. Vaccines Against Shigella Infections 843 i. Escherichia coli or Salmonella typhi Expressing Shigella Antigens 843 Thomas Larry Hale and Malabi M. Venkatesan ii. Engineered Attenuated Mutants of Shigella as Live Oral Vaccines 853 Fernando Noriega, Samuel B. Formal, Karen L. Kotloff, and Alf A. Lindberg 55. Vaccines Against Enterotoxigenic Escherichia coli Infections 865 i. Oral Inactivated Vaccines Against Enterotoxigenic Escherichia coli 865 Ann Mari L. Svennerholm, Christina khren, and Marianne Jertborn ii. Live Oral Vaccines and Subunit (Purified Fimbriae and Toxin Subunit) Vaccines 875 Carol O. Tacket and Myron M. Levine 56. Vaccines Against Campylobacter jejuni 885 Daniel A. Scott, Shahida Baqar, Donald H. Burr, Gary Pazzaglia, and Patricia Guerry 57. Vaccines Against Lyme Disease 897 Robert Edelman 58. Vaccines Against Dental Caries Infection 913 Daniel J. Smith and Martin A. Taubman 59. Vaccines Against Klebsiella, Pseudomonas, and Septicemic E. coli Infections 931 Alan S. Cross and Stanely J. Cryz, Jr. 60. Vaccines Against Escherichia coli and Proteus Urinary Tract Infections 945 Harry L. T. Mobley Contents • ix 61. Vaccines Against Helicobacter pylori 963 Adrian Lee and Christopher Doidge 62. Vaccines for Staphylococcus aureus Infections 979 AH I. Fattom and Robert B. Naso 63. Vaccines Against Malaria 989 i. Synthetic Peptide Vaccines Against the Sporozoite Stage of Plasmodium 989 Elizabeth H. Nardin and Ruth S. Nussenzweig ii. Vaccines Designed to Induce Protective T Cell Responses Against Plasmodium lnfected Hepatocytes 1009 John B. Sacci, Jr., Eileen D. Franke, and Stephen L. Hoffman iii. Spf66 Vaccine Against Asexual Erythrocytic Stages of P. falciparum 1027 Roberto Amador and Manuel E. Patarroyo iv. Vaccines Against Asexual Blood Stages of Plasmodium falciparum 1035 Robin F. Anders v. Vaccines Against Sexual Stage Parasites of P. falciparum: Transmission Blocking Vaccines 1057 David C. Kaslow 64. Vaccines Against Leishmaniasis 1065 Carol L. Eisenberger and Charles L Jaffe 65. Vaccines Against Schistosomiasis 1081 Gilles J. Riveau and Andre Capron Part VII: Vaccines Against Chronic Diseases, Vaccine Therapy, and Miscellaneous Vaccines 66. Antitumor Vaccines 1095 Karl Erik Hellstrom, Ingegerd Hellstrom, and Lieping Chen 67. Vaccine Therapy 1117 Donald S. Burke 68. Vaccines to Prevent Pregnancy 1131 Vernon C. Stevens and Warren R. Jones 69. An Anti arthropod Vaccine: TickGARD—A Vaccine to Prevent Cattle Tick Infestations 1145 Gary S. Cobon Part VIII: Commercial and Regulatory Aspects of Vaccine Production and Distribution 70. Large Scale Production of Live Attenuated Bacterial and Viral Vaccines 1153 Stanley J. Cryz, Jr., and Reinhard Gliick 71. Vaccine Development: The Long Road from Initial Idea to Product Licensure 1165 Jens Peter Gregersen 72. Inadvertant Nontarget Effects of Live Vaccines 1179 Myron M. Levine and Eileen M. Barry 73. The Role of the Food and Drug Administration in Vaccine Testing and Licensure 1185 Bascomb F. Anthony and Ann Sutton Index 7795
any_adam_object	1
building	Verbundindex
bvnumber	BV012270608
callnumber-first	Q - Science
callnumber-label	QR189
callnumber-raw	QR189
callnumber-search	QR189
callnumber-sort	QR 3189
callnumber-subject	QR - Microbiology
classification_rvk	XD 3300
ctrlnum	(OCoLC)36682381 (DE-599)BVBBV012270608
dewey-full	615/.372
dewey-hundreds	600 - Technology (Applied sciences)
dewey-ones	615 - Pharmacology and therapeutics
dewey-raw	615/.372
dewey-search	615/.372
dewey-sort	3615 3372
dewey-tens	610 - Medicine and health
discipline	Medizin
edition	2. ed., rev. and expanded
format	Book
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01388nam a2200409 c 4500</leader><controlfield tag="001">BV012270608</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19981120 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">981118s1997 ad\|\| \|\|\|\| 00\|\|\| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0824700619</subfield><subfield code="9">0-8247-0061-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)36682381</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV012270608</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-20</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QR189</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.372</subfield><subfield code="2">21</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XD 3300</subfield><subfield code="0">(DE-625)152554:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">New generation vaccines</subfield><subfield code="c">ed. by Myron M. Levine ...</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">2. ed., rev. and expanded</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York [u.a.]</subfield><subfield code="b">Dekker</subfield><subfield code="c">1997</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XVI, 1214 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Antigenen</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Infectieziekten</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Vaccins</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Vacinas</subfield><subfield code="2">larpcal</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccines</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Levine, Myron Max</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008316561&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-008316561</subfield></datafield></record></collection>
id	DE-604.BV012270608
illustrated	Illustrated
indexdate	2024-07-09T18:24:39Z
institution	BVB
isbn	0824700619
language	English
oai_aleph_id	oai:aleph.bib-bvb.de:BVB01-008316561
oclc_num	36682381
open_access_boolean
owner	DE-20
owner_facet	DE-20
physical	XVI, 1214 S. Ill., graph. Darst.
publishDate	1997
publishDateSearch	1997
publishDateSort	1997
publisher	Dekker
record_format	marc
spelling	New generation vaccines ed. by Myron M. Levine ... 2. ed., rev. and expanded New York [u.a.] Dekker 1997 XVI, 1214 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Antigenen gtt Infectieziekten gtt Vaccins gtt Vacinas larpcal Vaccines Impfstoff (DE-588)4026655-2 gnd rswk-swf Impfstoff (DE-588)4026655-2 s DE-604 Levine, Myron Max Sonstige oth HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008316561&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis
spellingShingle	New generation vaccines Antigenen gtt Infectieziekten gtt Vaccins gtt Vacinas larpcal Vaccines Impfstoff (DE-588)4026655-2 gnd
subject_GND	(DE-588)4026655-2
title	New generation vaccines
title_auth	New generation vaccines
title_exact_search	New generation vaccines
title_full	New generation vaccines ed. by Myron M. Levine ...
title_fullStr	New generation vaccines ed. by Myron M. Levine ...
title_full_unstemmed	New generation vaccines ed. by Myron M. Levine ...
title_short	New generation vaccines
title_sort	new generation vaccines
topic	Antigenen gtt Infectieziekten gtt Vaccins gtt Vacinas larpcal Vaccines Impfstoff (DE-588)4026655-2 gnd
topic_facet	Antigenen Infectieziekten Vaccins Vacinas Vaccines Impfstoff
url	http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008316561&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA
work_keys_str_mv	AT levinemyronmax newgenerationvaccines

Verfügbarkeit

Es ist kein Print-Exemplar vorhanden.

Fernleihe Bestellen Achtung: Nicht im THWS-Bestand! Inhaltsverzeichnis

MARC

Datensatz im Suchindex

Es ist kein Print-Exemplar vorhanden.

Ähnliche Einträge